Publications by authors named "Fraser Johnson"

Claim this Profile
M
MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.
Mayukha Bathini, Diana Bocaniciu, Fraser D Johnson, Rick C P de Jong, Fengchao Yu

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Ball Valve Gas Trapping in Pediatric One-Lung Ventilation: Not All Ventilation Is Loss of Isolation.
Anthony M-H Ho, Julie Zalan, Amanda Jasudavisius, Fraser Johnson, Glenio B Mizubuti

Paediatr Anaesth· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308.
Shaghayegh Nouruzi, Fraser Johnson, Sahil Kumar, Olena Sivak, Nakisa Tabrizian

Oncol Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the secretome of EGFR mutant lung adenocarcinoma.
Jennifer K Luu, Fraser D Johnson, Jana Jajarmi, Tianna Sihota, Rocky Shi

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methionine-producing tumor micro(be) environment fuels growth of solid tumors.
Alexis A Vega, Erin A Marshall, Avery J C Noonan, Fernando Sergio Leitao Filho, Julia Yang, Fraser D Johnson

Cell Oncol (Dordr)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.
Paalini Sathiyaseelan, Suganthi Chittaranjan, Steve E Kalloger, Jennifer Chan, Nancy E Go, Fraser D Johnson

J Cell Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells.
Fraser D Johnson, Christopher S Hughes, Alvin Liu, William W Lockwood, Gregg B Morin

STAR Protoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca flux to mitochondria.
Yibo Xue, Jordan L Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
Dylan A Farnsworth, Yusuke Inoue, Fraser D Johnson, Georgia de Rappard-Yuswack, Daniel Lu

NPJ Precis Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Etienne S Melese, Elizabeth Franks, Rachel A Cederberg, Bryant T Harbourne, Rocky Shi, Fraser Johnson

Oncoimmunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative positions of the right internal jugular vein and the right common carotid artery.
Fraser Johnson, Anthony M-H Ho, Rene Allard, Glenio B Mizubuti

Postgrad Med J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.
Fraser D Johnson, John Ferrarone, Alvin Liu, Christina Brandstädter, Ravi Munuganti

Cell Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca flux to mitochondria.
Yibo Xue, Jordan L Morris, Kangning Yang, Zheng Fu, Xianbing Zhu, Fraser Johnson

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.
Yusuke Inoue, Ana Nikolic, Dylan Farnsworth, Rocky Shi, Fraser D Johnson

Elife· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
Busra Turgu, Fan Zhang, Amal El-Naggar, Gian Luca Negri, Melanie Kogler, Fraser Johnson

Oncogene· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.
Katey S S Enfield, Erin A Marshall, Christine Anderson, Kevin W Ng, Sara Rahmati, Fraser D Johnson

Nat Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
Jennifer L Bishop, Daksh Thaper, Sepideh Vahid, Alastair Davies, Kirsi Ketola, Fraser Johnson

Cancer Discov· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined AKT and MEK Pathway Blockade in Pre-Clinical Models of Enzalutamide-Resistant Prostate Cancer.
Paul Toren, Soojin Kim, Fraser Johnson, Amina Zoubeidi

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis